Abstract:ABSTRACT Porcine reproductive and respiratory syndrome virus (PRRSV) is an RNA virus with constantly emerging recombinant and mutant strains. Because of the high genetic diversity of PRRSV, current vaccines only provide partial protection against the infection of heterologous strains, which makes it a challenge for PRRSV prevention and control. Tubercidin is a naturally extracted compound with potential antiviral properties. However, whether tubercidin has anti-PRRSV ability is unknown. Our study found that tubercidin showed effective antiviral effects on PRRSV replication. In terms of mechanism, tubercidin suppressed PRRSV at the entry, replication, and release steps of the viral life cycle. Additionally, we demonstrated that tubercidin treatment promoted the activation of retinoic acid-inducible gene I and nuclear factor kappa-light-chain-enhancer of activated B cell signaling pathway, thus increasing the type I interferon and inflammatory cytokine expression. Furthermore, tubercidin restrained the viral non-structural protein 2 expression and viral dsRNA synthesis and ultimately inhibited PRRSV replication. Hence, our data showed that tubercidin is promising and has potential antiviral ability against PRRSV replication in vitro . IMPORTANCE Porcine reproductive and respiratory syndrome (PRRS) is one of the most important swine diseases, which causes huge economic loss worldwide. However, there is no effective therapeutic method for PRRS prevention and control. Here, we found that tubercidin, a naturally extracted adenosine analog, exhibited strong anti-porcine reproductive and respiratory syndrome virus (PRRSV) activity. Mechanically, tubercidin inhibited viral binding, replication, and release. Tubercidin suppressed PRRSV non-structural protein 2 expression, which is important for the formation of replication and transcription complex, leading to the block of viral RNA synthesis and PRRSV replication. Moreover, tubercidin could activate retinoic acid-inducible gene I/nuclear factor kappa-light-chain-enhancer of activated B cell innate immune signaling pathway and increased the expression of interferons and proinflammatory cytokines, which was the other way to inhibit PRRSV replication. Our work evaluated the potential value of tubercidin as an antiviral agent on PRRSV replication and provided a new way to prevent PRRSV replication in vitro .

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: the difficult problem of prevention and control of porcine reproductive and respiratory syndrome virus (PRRSV) infection. Due to the high genetic diversity of PRRSV, the existing vaccines can only provide partial protection, which makes the prevention and control of PRRSV very difficult. Therefore, the researchers explored whether the natural extract tubercidin has the ability to resist PRRSV. Specifically, the paper discussed the inhibitory effect of tubercidin on PRRSV replication and its mechanism, including inhibiting PRRSV replication by activating the RIG - I/NF - κB signaling pathway and interfering with the synthesis of viral non - structural protein 2 (nsp2). ### Main research questions: 1. **Does tubercidin have the ability to resist PRRSV?** - The researchers evaluated the inhibitory effect of tubercidin on PRRSV replication in vitro. 2. **How does tubercidin inhibit PRRSV replication?** - Through a variety of experimental methods, the researchers explored the inhibitory effect of tubercidin at different stages of the virus life cycle (such as virus entry, replication, and release). 3. **Can tubercidin activate the innate immune response?** - The researchers investigated whether tubercidin can promote the activation of the RIG - I/NF - κB signaling pathway, thereby increasing the expression of type I interferon and inflammatory cytokines. 4. **Can tubercidin inhibit the expression of PRRSV non - structural protein 2 (nsp2)?** - The researchers analyzed the effect of tubercidin on the expression of PRRSV nsp2 and how this effect blocks the synthesis of viral RNA and the replication of PRRSV. ### Experimental design and results: - **Cytotoxicity experiment**: The cytotoxicity of tubercidin at different concentrations was detected using the CCK - 8 kit, and the appropriate experimental concentrations were determined. - **Antiviral activity experiment**: Through Western Blot, RT - qPCR and immunofluorescence analysis, it was confirmed that tubercidin significantly reduced the expression of PRRSV N protein at different concentrations. - **Virus life cycle experiment**: Through binding, entry, replication and release experiments, it was found that tubercidin can prevent virus entry, replication and release, but does not affect virus attachment. - **Signaling pathway activation experiment**: Through Western Blot and confocal microscopy analysis, it was confirmed that tubercidin can activate the RIG - I/NF - κB signaling pathway and increase the expression of type I interferon and inflammatory cytokines. - **nsp2 expression experiment**: Through Western Blot analysis, it was found that tubercidin can inhibit the expression of PRRSV nsp2, thereby blocking the synthesis of viral RNA and replication. ### Conclusion: This study shows that tubercidin has significant anti - PRRSV activity in vitro, and its mechanism includes activating the innate immune response through the RIG - I/NF - κB signaling pathway and inhibiting the expression of PRRSV nsp2. These findings provide a potential therapeutic approach for the development of new PRRSV prevention and control strategies.

Tubercidin inhibits PRRSV replication via RIG-I/NF-κB pathways and interrupting viral nsp2 synthesis

Porcine reproductive and respiratory syndrome virus regulates lipid droplet accumulation in lipid metabolic pathways to promote viral replication

Molecular Characterization of Three Porcine Reproductive and Respiratory Syndrome Virus Isolates and Their Susceptibility to Antiviral Drugs

Synthetic Toll-like receptor 7 ligand inhibits porcine reproductive and respiratory syndrome virus infection in primary porcine alveolar macrophages

Identification and Characterization of Small Molecule Inhibitors of Porcine Reproductive and Respiratory Syndrome Virus

PP2A Facilitates Porcine Reproductive and Respiratory Syndrome Virus Replication by Deactivating Irf3 and Limiting Type I Interferon Production

Inhibition of Porcine Reproductive and Respiratory Syndrome Virus Replication by Adenovirus-Mediated RNA Interference Both in Porcine Alveolar Macrophages and Swine.

A nanobody inhibiting porcine reproductive and respiratory syndrome virus replication via blocking self-interaction of viral nucleocapsid protein

Platycodin D Suppresses Type 2 Porcine Reproductive And Respiratory Syndrome Virus In Primary And Established Cell Lines

Knock down of transforming growth factor beta improves expressions of co-stimulatory molecules, type I interferon-regulated genes, and pro-inflammatory cytokine in PRRSV-inoculated monocyte-derived macrophages

Bergamottin Inhibits PRRSV Replication by Blocking Viral Non-Structural Proteins Expression and Viral RNA Synthesis

A synthetic toll-like receptor 7 agonist inhibits porcine reproductive and respiratory syndrome virus replication in piglets

Drug repurposing screens identify Tubercidin as a potent antiviral agent against porcine nidovirus infections

Inhibition Effect of STING Agonist SR717 on PRRSV Replication

Poly(I:C) Inhibits Porcine Reproductive and Respiratory Syndrome Virus Replication in MARC-145 Cells Via Activation of IFIT3

Therapeutic efficacy of tylvalosin combined with Poria cocos polysaccharides against porcine reproductive and respiratory syndrome

A novel strategy to attenuate porcine reproductive and respiratory syndrome virus by inhibiting viral replication in the target pulmonary alveolar macrophages via hematopoietic-specific miR-142

Cryptoporus Volvatus Extract Inhibits Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) in Vitro and in Vivo

The Natural Compound Sanggenon C Inhibits PRRSV Infection by Regulating the TRAF2/NF-κB Signalling Pathway.

Ursolic acid derivatives are potent inhibitors against porcine reproductive and respiratory syndrome virus

Type I and II interferons, transcription factors and major histocompatibility complexes were enhanced by knocking down the PRRSV-induced transforming growth factor beta in monocytes co-cultured with peripheral blood lymphocytes